OpenAI · Business
Orchestra Bio to be acquired, targeting life sciences R&D
OpenAI says the deal would bring AI-powered operations to life sciences R&D, helping biopharma teams speed up drug development and advance new treatments.
Read it on openai.com ↗OpenAI acquires Orchestra Bio